Kin and Carta plc is a specialty business services business based in the UK. Kin and Carta shares (KCT.LSE) are listed on the London Stock Exchange (LSE) and all prices are listed in pence sterling. Its last market close was 106.5p – a decrease of 1.39% over the previous week. Kin and Carta employs 1,161 staff and has a trailing 12-month revenue of around £137.7 million.
Since the stock market crash in March caused by coronavirus, Kin and Carta's share price has had significant negative movement.
Its last market close was 106.5p, which is 4.05% down on its pre-crash value of 111p and 102.47% up on the lowest point reached during the March crash when the shares fell as low as 52.6p.
If you had bought £1,000 worth of Kin and Carta shares at the start of February 2020, those shares would have been worth £521.33 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £1,009.48.
|Latest market close||106.5p|
|52-week range||48p - 137.5p|
|50-day moving average||105.7368p|
|200-day moving average||75.0278p|
|Wall St. target price||148.5p|
|Dividend yield||0.02p (3.45%)|
|Earnings per share (TTM)||0.7p|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2021-01-14)||-29.50%|
|1 month (2020-12-22)||-17.38%|
|3 months (2020-10-22)||38.05%|
|6 months (2020-07-21)||82.33%|
|1 year (2020-01-21)||-0.24%|
|2 years (2019-01-21)||2.08%|
|3 years (2018-01-19)||41.95%|
|5 years (2016-01-21)||-50.47%|
Valuing Kin and Carta stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Kin and Carta's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Kin and Carta's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 147x. In other words, Kin and Carta shares trade at around 147x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Kin and Carta's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £19.1 million.
The EBITDA is a measure of a Kin and Carta's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||£137.7 million|
|Operating margin TTM||1.87%|
|Gross profit TTM||£67.3 million|
|Return on assets TTM||0.86%|
|Return on equity TTM||-42.9%|
|Market capitalisation||£226 million|
TTM: trailing 12 months
We're not expecting Kin and Carta to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Kin and Carta's shares were split on a 2:1 basis on 7 December 1987. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Kin and Carta shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Kin and Carta shares which in turn could have impacted Kin and Carta's share price.
Over the last 12 months, Kin and Carta's shares have ranged in value from as little as 48p up to 137.5p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Kin and Carta's is 1.1204. This would suggest that Kin and Carta's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Kin and Carta plc provides digital transformation services in the United Kingdom, the United States, and internationally. The company helps its clients to invent, operate, and market digital products and services. It offers tech and data-led management consulting services; software engineering and product design services; and digital marketing and customer connected services. Kin and Carta plc serves healthcare, financial services, transportation, industrial and agriculture, retail and distribution, and other sectors. The company was formerly known as St Ives plc and changed its name to Kin and Carta plc in October 2018. Kin and Carta plc was incorporated in 1981 and is headquartered in London, the United Kingdom.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.